- Barbour JD, Grant RM. The role of viral fitness in HIV pathogenesis. Curr. HIV/AIDS Rep. 2:29–34, 2005.
- Bisgrove D, Lewinski M, Bushman F, Verdin E. Molecular mechanisms of HIV-1 proviral latency. Expert Rev. Anti-Infect. Ther. 3:805–814, 2005.
- Chatterji U, Bobardt MD, Stanfield R, Ptak RG, Pallansch LA, Ward PA, Jones MJ, Stoddart CA, Scalfaro P, Dumont JM, Besseghir K, Rosenwirth B, Gallay PA. Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in owl monkey cells. J. Biol. Chem. 280:40293–40300, 2005.
- Chen L-F, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder LM, Greene WC. NF-kB RelA phosphorylation regulates RelA acetylation. Mol. Cell. Biol. 25:7966–7975, 2005.
- Chen L-f, Greene WC. Assessing Acetylation of NF-kB. Methods 36:368–375, 2005.
- Chin-Hong PV, Deeks SG, Liegler T, Hagos E, Krone MR, Grant RM, Martin JN. High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. J. Acquir. Immune Defic. Syndr. 40:463–471, 2005.
- Chiu Y-L, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435:108–114, 2005.
- Deeks SG, Hoh R, Neilands TB, Liegler T, Aweeka F, Petropoulos CJ, Grant RM, Martin JN. Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection. J. Infect. Dis. 192:1537–1544, 2005.
- Dormeyer W, Ott M, Schnolzer M. Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry. Methods 36:376–382, 2005.
- Dormeyer W, Ott M, Schnolzer M. Probing lysine acetylation in proteins: strategies, limitations and pitfalls of in vitro acetyltransferase assays. Mol. Cell Proteomics 4:1226–1239, 2005.
- Emu B, Sinclair E, Favre D, Moretto WJ, Hsue P, Hoh R, Martin JN, Nixon DF, McCune JM, Deeks S. Phenotypic, functional, and kinetic parameters associated with apparent T cell control of HIV replication in both antiretroviral treated and untreated individuals. J. Virol. 79:14169–14178, 2005.
- Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC. Nef is physically recruited into the immunological synapse and potentiates T-cell activation early after TCR engagement. J. Immunol. 175:6050–6057, 2005
- Grant RM, Buchbinder S, Cates W Jr., Clarke E, Coates T, Cohen MS, Delaney M, Flores G, Goicochea P, Gonsalves G, Harrington M, Lama JR, MacQueen KM, Moore JP, Peterson L, Sanchez J, Thompson M, Wainberg MA. AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science 309:2170–2171, 2005.
- Harris JM, Hazenburg MD, Poulin JF, Higuera-Alhino D, Schmidt D, Gotway M, McCune JM. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin. Immunol. 115:138–146, 2005.
- Hanley MB, Napolitano LA, McCune JM. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells 23:1170–1179, 2005.
- Hecht FM, Grant RM. Resistance testing in drug-naive HIV-infected patients: is it time? Clin. Infect. Dis. 41:1324–1325, 2005.
- Hetzer C, Dormeyer W, Schnolzer M, Ott M. Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes. Infect. 7:1364–1369, 2005.
- Jayakumar P, Berger I, Autschbach F, Weinstein M, Funke B, Verdin E, Goldsmith MA, Keppler OT. Tissue-resident macrophages are productively infected ex vivo by primary X4 isolates of human immunodeficiency virus type 1. J. Virol. 79:5220–5226, 2005.
- Keppler OT, Allespach I, Schüller L, Fenard D, Greene WC, Fackler OT. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79:1655–1665, 2005.
- Klausner JD, Grant RM, Kent CK. Detection of acute HIV infections. N. Engl. J. Med. 353:631–633, 2005.
- Kreisberg JF, Doitsh G, Greene WC. Mechanisms of HIV-infected versus uninfected T-cell killing. In: Cell Death During HIV Infection Badley AD (Ed), CRC Press, Boca Raton, FL, 2005, pp. 207–228.
- Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW, Greene WC. Lethal cutaneous disease in transgenic mice conditionally expressing HTLV-I Tax. J. Biol. Chem. 280:35713–35722, 2005.
- Legrand FA, Abadi J, Jordan KA, Davenport MP, Deeks SG, Fennelly GJ, Wiznia AA, Nixon DF, Rosenberg MG. Partial treatment interruption of protease inhibitors augments HIV-specific immune reponses in vertically infected pediatric patients. AIDS 19:1575–1585, 2005.
- Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli S, Verdin E, Berry CC, Ecker JR, Bushman FD. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79:6610–6619, 2005.
- Metzner KJ, Moretto WJ, Donahoe SM, Jin X, Gettie A, Montefiori DC, Marx PA, Binley JM, Nixon DF, Connor RI. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus. J. Gen. Virol. 86:3375–3384, 2005.
- Napolitano LA, Burt TD, Bacchetti P, Barron Y, French AL, Kovacs A, Anastos K, Young M, McCune JM, Greenblatt RM. Increased circulating interleukin-7 levels in HIV-1-infected women. J. Acquir. Immune Defic. Syndr. 40:581–584, 2005.
- Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS 19:1351–1359, 2005.
- Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J. AIDS 39:16–22, 2005.
- Nixon DF, Aandahl EM, Michaelsson J. CD4(+)CD25(+) regulatory T cells in HIV infection. Microbes. Infect. 7:1063–1065, 2005.
- Nixon DF, Deeks SG, Shacklett BL, Karlsson AC. Multidrug-resistant, dual-tropic HIV-1 and rapid progression. Lancet 365:1924–1925, 2005.
- North BJ, Schwer B, Ahuja N, Marshall B, Verdin E. Preparation of enzymatically active recombinant class III protein deacetylases. Methods 36:338–345, 2005.
- Pagans S, Pedal A, North BJ, Kaelcke K, Marshall BL, Dorr A, Hetzer-Egger C, Henklein P, Frye R, McBurney MW, Hruby H, Jung M, Verdin E, Ott M. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3:210–220, 2005.
- Parra M, Kasler H, McKinsey TA, Olson EN, Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J. Biol. Chem. 280:13762–13770, 2005.
- Roland ME, Neilands TB, Krone MR, Katz MH, Franses K, Grant RM, Busch MP, Hecht FM, Shacklett BL, Kahn JO, Bamberger JD, Coates TJ, Chesney MA, Martin JN. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin. Infect. Dis. 41:1507–1513, 2005.
- Roy AM, Schweighart B, Eckstein LA, Goldsmith MA, McCune JM. Enhanced replication of R5 HIV-1 over X4 HIV-1 in CD4(+)CCR5(+)CXCR4(+) T cells. J. Acquir. Immune Defic. Syndr. 40:267–275, 2005.
- Sanchez MS, Grant RM, Porco TC, Gross KL, Getz WM. A decrease in drug resistance levels of the HIV epidemic can be bad news. Bull. Math. Biol. 67:761–782, 2005.
- Sharp ER, Barbour JD, Karlsson RK, Jordan KA, Sandberg JK, Wiznia A, Rosenberg MG, Nixon DF. Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. J. Infect. Dis. 192:1772–1780, 2005.
- Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW. HIV-1 chemokine co-receptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. J. Infect. Dis. 191:890–898, 2005.
- Stopak K, Greene WC. Protecting APOBEC3G: A potential new target for HIV drug discovery. Curr. Opin. Invest. Drugs. 6:141–147, 2005.
- Waltregny D, Glenisson W, Tran SL, North BJ, Verdin E, Colige A, Castronovo V. Histone deacetylase HDAC8 associates with smooth muscle a-actin and is essential for smooth muscle cell contractility. FASEB J. 19:966–968, 2005.
- Williams SAF, Greene WC. Host factors regulating post-integration latency of HIV. Trends Microbiol. 14:137–130, 2005.
- Wittich S, Scherf H, Xie C, Heltweg B, Dequiedt F, Verdin E, Gerhauser C, Jung M. Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. Anticancer Drugs 16:635–643, 2005.
- Yonezawa A, Cavrois M, Greene WC. Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped HIV-1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor a. J. Virol. 79:918–926, 2005.
|
